Clinical Trial Update: Patient's Management Receiving Eplerenone Therapy

View source ↗

Summary

Completed clinical trial evaluating management of patients receiving eplerenone therapy in left ventricular dysfunction after myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure Following Myocardial Infarction
• Left Ventricular Dysfunction

Drugs mentioned

• eplerenone (eplerenone)

Snippet

Sponsor: Pfizer | Conditions: Left Ventricular Dysfunction Post Myocardial Infarction | Status: COMPLETED | Results posted: 2013-01-30